1,4-Dichlorobenzene

1,4-Dichlorobenzene

SCHEMBL3214891

Clc1ccc(Cl)cc1.OBO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.67
▸ CYP2A6 P11509 1/20 0.67
▸ CES2 O00748 1/20 0.47
▸ CES1 P23141 1/20 0.47
▸ ENPP2 Q13822 1/20 0.47
▸ IDO1 P14902 2/20 0.47
▸ TSHR P16473 4/20 0.45
▸ MAPK1 P28482 3/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ CA1 P00915 2/20 0.43
▸ CA2 P00918 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ HTR3E A5X5Y0 1/20 0.41
▸ SLC22A2 O15244 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3322838 0.84 CES2 (0.58) LMNACYP2A6CES2CES1TSHR
SCHEMBL28682658 0.84 LMNA (0.47) LMNACYP2A6TSHRMEN1KMT2A
SCHEMBL28501382 0.84 CYP2A6 (0.47) LMNACYP2A6CES2CES1ENPP2
Chlorobenzene SCHEMBL290137 0.82 TSHR (0.73) LMNACYP2A6CES2CES1IDO1
1,4-Dichlorobenzene SCHEMBL5191 0.82 — —
1,4-Dichlorobenzene SCHEMBL11243685 0.82 — —
SCHEMBL15951989 0.80 CYP1A2 (0.79) LMNACES2CES1TSHRL3MBTL1
SCHEMBL972392 0.79 — —
SCHEMBL28738846 0.78 HSD17B10 (0.80) LMNACYP2A6CYP1A2ALDH1A1HSD17B10
SCHEMBL1990707 0.78 HPGD (0.63) LMNATSHRMAPK1L3MBTL1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035871-A1 BENZOXAZINE DERIVATIVES AND USES THEREOF WYETH 2010-02-11 — — US disclosed
WO-2008052075-A2 BENZOXAZINE DERIVATIVES AND USES THEREOF WYETH (US) 2008-05-02 — — WO disclosed
EP-1871759-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF Wyeth a Corporation of the State of Delaware (US) 2008-01-02 — — EP disclosed
WO-2006116158-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF WYETH (US) 2006-11-02 — — WO disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof HTR2C, HTR1D, HTR1A LMNA 2921/4885CYP2A6 481/4885CES2 792/4885
US-20100035871-A1 BENZOXAZINE DERIVATIVES AND USES THEREOF HTR2C, HTR5A, NPY1R LMNA 2272/4885CYP2A6 576/4885CES2 954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback